Drugs / Fluval AB Novo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02387294 | Oct → Dec 2014 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01407978 Comparator | Aug 2009 → Mar 2010 | swine influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluval AB Novo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01407978 ↗ |
| Modality | Vaccine | “trivalent, seasonal influenza vaccine” NCT02387294 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT02387294 ↗ |